UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platelet activation in type 2 diabetes mellitus

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1282-1291

2004

Volltextzugriff (PDF)

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Lipids, 2020-01, Vol.55 (1), p.73-78

2020

Volltextzugriff (PDF)

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Thrombosis and haemostasis, 2011-09, Vol.106 (3), p.491-499

2011

Volltextzugriff (PDF)

Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients

Thrombosis and haemostasis, 2015-08, Vol.114 (2), p.289-296

2015

Volltextzugriff (PDF)

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Molecular and cellular biochemistry, 2020-01, Vol.463 (1-2), p.147-160

2020

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Prostaglandins & other lipid mediators, 2018-01, Vol.134, p.24-31

2018

Volltextzugriff (PDF)

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Circulation research, 2018-02, Vol.122 (4), p.555-559

2018

Volltextzugriff (PDF)

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (39), p.15812-15817

2013

Volltextzugriff (PDF)

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Circulation (New York, N.Y.), 2007-04, Vol.115 (16), p.2196-2207

2007

Volltextzugriff (PDF)

Effects of immunosuppressive agents on the hemostatic system in normal dogs

Journal of veterinary internal medicine, 2018-07, Vol.32 (4), p.1325-1333

2018

Volltextzugriff (PDF)

High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure

Circulation (New York, N.Y.), 2016-10, Vol.134 (17), p.1303-1305

2016

Volltextzugriff (PDF)

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Journal of veterinary pharmacology and therapeutics, 2018-02, Vol.41 (1), p.60-67

2018

Volltextzugriff (PDF)

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Journal of veterinary internal medicine, 2013-01, Vol.27 (1), p.141-149

2013

Volltextzugriff (PDF)

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2462-2469

2012

Volltextzugriff (PDF)

d-galactose induced inflammation lipid peroxidation and platelet activation in rats

Cytokine (Philadelphia, Pa.), 2014-09, Vol.69 (1), p.150-153

2014

Volltextzugriff (PDF)

Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels

Clinica chimica acta, 2014-02, Vol.429, p.76-78

2014

Volltextzugriff (PDF)

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy

Circulation (New York, N.Y.), 2002-07, Vol.106 (4), p.399-402

2002

Volltextzugriff (PDF)

Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: Another example of developmental hemostasis?

Pediatric blood & cancer, 2014-11, Vol.61 (11), p.2074-2076

2014

Volltextzugriff (PDF)

Cyclooxygenase Polymorphisms and Risk of Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Study

Clinical pharmacology and therapeutics, 2008-01, Vol.83 (1), p.52-60

2008

Volltextzugriff (PDF)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease

Drug design, development and therapy, 2018-01, Vol.12, p.1353-1362

2018

Volltextzugriff (PDF)

Low‐dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor

British journal of pharmacology, 2009-03, Vol.156 (5), p.774-785

2009

Volltextzugriff (PDF)

Acceleration of Atherogenesis by COX-1-Dependent Prostanoid Formation in Low Density Lipoprotein Receptor Knockout Mice

Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (6), p.3358-3363

2001

Volltextzugriff (PDF)

Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes

European journal of pediatrics, 2015-07, Vol.174 (7), p.933-941

2015

Volltextzugriff (PDF)

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism

Thrombosis and haemostasis, 2012-09, Vol.108 (3), p.533-542

2012

Volltextzugriff (PDF)

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration

Circulation (New York, N.Y.), 2003-07, Vol.107 (25), p.3199-3203

2003

Volltextzugriff (PDF)

1 – 25 von 660

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect_期刊（NSTL购买）

Zeitschrift / SerieThrombosis Research

ThemaAdult

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(548)
Mit Volltextzugriff
(470)

Publikationsform

Artikel
(660)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(454)
Life Sciences & Biomedicine
(434)
Animals
(430)
Male
(304)
Biological And Medical Sciences
(286)
Humans
(269)
Thromboxane B2 - Analogs & Derivatives
(205)
Medical Sciences
(195)
Thromboxane B2 - Blood
(195)
Female
(191)
Thromboxane B2 - Urine
(175)
Rats
(172)
Thromboxane B2 - Metabolism
(162)
Thromboxane B2 - Biosynthesis
(119)
Pharmacology. Drug Treatments
(106)
Biochemistry & Molecular Biology
(105)
Pharmacology & Pharmacy
(105)
Fundamental And Applied Biological Sciences. Psychology
(96)
Blood Platelets - Drug Effects
(80)
Platelet Aggregation - Drug Effects
(80)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Platelet activation in type 2 diabetes mellitus

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Effects of immunosuppressive agents on the hemostatic system in normal dogs

High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

d-galactose induced inflammation lipid peroxidation and platelet activation in rats

Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy

Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: Another example of developmental hemostasis?

Cyclooxygenase Polymorphisms and Risk of Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Study

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease

Low‐dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor

Acceleration of Atherogenesis by COX-1-Dependent Prostanoid Formation in Low Density Lipoprotein Receptor Knockout Mice

Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration

Aktive Filter

Suchergebnisse filtern